Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins

砷与 UVR 的协同致癌作用:目标蛋白的亚硝化和氧化

基本信息

项目摘要

DESCRIPTION (provided by applicant): Widespread human exposure to arsenic through drinking water at levels in excess of the Environmental Protection Agency and World Health Organization minimum contaminant level of 10 �g/L is a national and international concern. It is becoming increasingly appreciated that low and non-cytotoxic concentrations of arsenic can amplify the DNA damaging and carcinogenic potential of other genotoxic agents such as ultraviolet radiation, at least in part, through inhibition of DNA repair processes. The mechanisms by which arsenic inhibits DNA repair target proteins is central to understanding the carcinogenic and co-carcinogenic potential of arsenic and to identify avenues to reverse or prevent the adverse effects of arsenic exposure in human populations. The current project will test the hypothesis that arsenic-generated reactive oxygen and nitrogen species inhibits the activity of zinc finger DNA repair proteins through reaction with redox-sensitive cysteine residues of the zinc finger domains. In Aim 1 we will investigate the impact of arsenic-mediated iNOS and NADPH oxidase (NOX) induction and subsequent nitric oxide and superoxide generation on the activity of two DNA repair proteins (XPA and PARP-1), DNA repair and genotoxicity in keratinocytes. Genetic and pharmacologic disruption of iNOS and NOX will define which pathway(s) are involved in arsenic-mediated inhibition of DNA repair. Aim 2 will investigate the interaction of arsenic-generated reactive oxygen and nitrogen species with the zinc fingers of XPA and PARP-1 and apply analytical techniques to define specific modifications of the zinc finger domain and consequences with regard to zinc binding. Data generated by our laboratories and others indicate selectivity for arsenic binding to zinc finger structures and we find that arsenic- bound, but not zinc bound, zinc finger peptide is highly vulnerable to oxidation We will test whether arsenic binding to a zinc finger translates to targeted oxidative and nitrosative modification and loss of zinc finger protein function. In Aim 3, we will test the iNOS and NOX dependence for the reported synergism between arsenic and ultraviolet radiation in DNA damage and skin tumorigenesis in vivo using genetic models. Thus, this project rigorously tests mechanisms of arsenic inhibition of key DNA repair target proteins using a multi- faceted approach. The outcomes from these studies will improve our understanding of mechanisms underlying arsenic disruption of zinc finger DNA repair protein function and may have significant impact on treatments or preventative interventions for arsenic exposed populations. Additionally, these studies may lead to testable hypotheses regarding potential arsenic targets in cancer and other arsenic-associated diseases.
描述(由适用提供):通过饮用水的宽度宽度超过环境保护局和世界卫生组织的水平,最低污染物水平为10'g/l是国家和国际上的关注点。越来越多的人越来越多地认为,砷的低和非毒性浓度可以扩大其他遗传毒性剂(例如紫外线辐射)的DNA损伤和致癌潜力,至少部分通过抑制DNA修复过程。砷抑制DNA修复靶蛋白的机制对于理解砷的致癌和共同致癌潜力至关重要,并确定途径以逆转或防止人群中砷暴露的不利影响。当前的项目将检验以下假设:砷生成的活性氧和氮种通过与氧化还原敏感的半胱氨酸保留锌指域抑制锌指DNA修复蛋白的活性。在AIM 1中,我们将研究砷介导的INOS和NADPH氧化物(NOX)诱导以及随后的一氧化氮和超氧化物的产生对两种DNA修复蛋白(XPA和PARP-1),DNA修复和遗传毒性的活性。 iNOS和NOX的遗传和药物破坏将定义哪些途径参与砷介导的DNA修复抑制。 AIM 2将研究砷生成的活性氧和氮种与XPA和PARP-1的锌指的相互作用,并应用分析技术来定义锌指域的特定修饰,以及对锌结合的后果。 Data generated by our laboratories and others indicate selectivity for arsenic binding to zinc finger structures and we find that arsenic-bound, but not zinc bound, zinc finger peptide is highly vulnerable to oxidation We will test whether arsenic binding to a zinc finger translates to targeted oxidative and nitrosative modification and loss of zinc finger protein function.在AIM 3中,我们将使用遗传模型在DNA损伤和紫外线辐射之间在DNA损伤和皮肤肿瘤发生中报告的INOS和NOX依赖性。这是该项目严格测试使用多方面方法对关键DNA修复靶蛋白砷抑制的机制。这些研究的结果将提高我们对锌指DNA修复蛋白功能的砷破坏机制的理解,并可能对砷暴露群体的治疗或预防干预措施产生重大影响。此外,这些研究可能导致有关癌症和其他砷相关疾病的潜在砷靶标的可检验的假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURIE G HUDSON其他文献

LAURIE G HUDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURIE G HUDSON', 18)}}的其他基金

Pilot Project Core
试点项目核心
  • 批准号:
    10393303
  • 财政年份:
    2022
  • 资助金额:
    $ 33.98万
  • 项目类别:
Pilot Project Core
试点项目核心
  • 批准号:
    10689705
  • 财政年份:
    2022
  • 资助金额:
    $ 33.98万
  • 项目类别:
Illuminating the functions and translational potential of CDC42BP/MRCK kinases in ovarian cancer
阐明 CDC42BP/MRCK 激酶在卵巢癌中的功能和翻译潜力
  • 批准号:
    10216717
  • 财政年份:
    2021
  • 资助金额:
    $ 33.98万
  • 项目类别:
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
综合环境暴露的突变特征:砷和紫外线辐射
  • 批准号:
    10844717
  • 财政年份:
    2020
  • 资助金额:
    $ 33.98万
  • 项目类别:
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
综合环境暴露的突变特征:砷和紫外线辐射
  • 批准号:
    10330581
  • 财政年份:
    2020
  • 资助金额:
    $ 33.98万
  • 项目类别:
Biomarkers and mechanisms of metal and mixed metal exposures
金属和混合金属暴露的生物标志物和机制
  • 批准号:
    10707512
  • 财政年份:
    2017
  • 资助金额:
    $ 33.98万
  • 项目类别:
Biomarkers and mechanisms of metal and mixed metal exposures
金属和混合金属暴露的生物标志物和机制
  • 批准号:
    10353202
  • 财政年份:
    2017
  • 资助金额:
    $ 33.98万
  • 项目类别:
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
锌对砷协同致癌作用的化学预防
  • 批准号:
    8762020
  • 财政年份:
    2014
  • 资助金额:
    $ 33.98万
  • 项目类别:
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
锌对砷协同致癌作用的化学预防
  • 批准号:
    9325454
  • 财政年份:
    2014
  • 资助金额:
    $ 33.98万
  • 项目类别:
Capitalizing on NSAID enantiomer selectivity for cancer prevention and therapy(PQ
利用 NSAID 对映体选择性进行癌症预防和治疗 (PQ
  • 批准号:
    8625502
  • 财政年份:
    2012
  • 资助金额:
    $ 33.98万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Sleep-Wake Cycles of Individuals with Inflammatory Bowel Disease
炎症性肠病患者的睡眠-觉醒周期
  • 批准号:
    10604701
  • 财政年份:
    2023
  • 资助金额:
    $ 33.98万
  • 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
  • 批准号:
    10735117
  • 财政年份:
    2023
  • 资助金额:
    $ 33.98万
  • 项目类别:
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
  • 批准号:
    10722518
  • 财政年份:
    2023
  • 资助金额:
    $ 33.98万
  • 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
  • 批准号:
    10726508
  • 财政年份:
    2023
  • 资助金额:
    $ 33.98万
  • 项目类别:
The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure
m6A-RNA 甲基化在记忆形成和回忆中的作用及其对早期铅暴露对长期结果的影响
  • 批准号:
    10658020
  • 财政年份:
    2023
  • 资助金额:
    $ 33.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了